Found: 94
Select item for more details and to access through your institution.
Antiretroviral drug treatment of CNS HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 2, p. 299, doi. 10.1093/jac/dkr492
- By:
- Publication type:
- Article
Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
- Published in:
- Journal of NeuroVirology, 2019, v. 25, n. 2, p. 150, doi. 10.1007/s13365-018-0696-3
- By:
- Publication type:
- Article
Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1012470
- By:
- Publication type:
- Article
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 9, p. 3159, doi. 10.1172/JCI64575
- By:
- Publication type:
- Article
Infection of the Central Nervous System by Human Immunodeficiency Virus Role of the Immune System in Pathogenesisa.
- Published in:
- Annals of the New York Academy of Sciences, 1988, v. 540, n. 1, p. 162, doi. 10.1111/j.1749-6632.1988.tb27059.x
- By:
- Publication type:
- Article
Latent infection of the peripheral ANS with herpes simplex virus.
- Published in:
- Nature, 1975, v. 257, n. 5528, p. 686, doi. 10.1038/257686a0
- By:
- Publication type:
- Article
Brain MRI Features of CSF Human Immunodeficiency Virus Escape.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
- Published in:
- Journal of NeuroVirology, 2004, v. 10, p. 44, doi. 10.1080/13550280490268223
- By:
- Publication type:
- Article
HIV-1 Chemokine Coreceptor Utilization in Paired Cerebrospinal Fluid and Plasma Samples: A Survey of Subjects with Viremia.
- Published in:
- Journal of Infectious Diseases, 2005, v. 191, n. 6, p. 890, doi. 10.1086/428095
- By:
- Publication type:
- Article
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A Pilot Study of the Discontinuation of Antifungal Therapy for Disseminated Cryptococcal Disease in Patients with Acquired Immunodeficiency Syndrome, following Immunologic Response to Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 8, p. 1179, doi. 10.1086/339680
- By:
- Publication type:
- Article
Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 5, p. 753
- By:
- Publication type:
- Article
Neuroimmunology of CNS HIV Infection: A Narrative Review.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.843801
- By:
- Publication type:
- Article
Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0116081
- By:
- Publication type:
- Article
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088591
- By:
- Publication type:
- Article
Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066188
- By:
- Publication type:
- Article
Lessons Learned Developing a Diagnostic Tool for HIV-Associated Dementia Feasible to Implement in Resource-Limited Settings: Pilot Testing in Kenya.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032898
- By:
- Publication type:
- Article
Utility of Quantitative Sensory Testing and Screening Tools in Identifying HIV-Associated Peripheral Neuropathy in Western Kenya: Pilot Testing.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0014256
- By:
- Publication type:
- Article
Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0006877
- By:
- Publication type:
- Article
Screening for HIV-associated peripheral neuropathy in resource-limited settings.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 4, p. 516, doi. 10.1002/mus.23795
- By:
- Publication type:
- Article
An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy.
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. 10, p. 1618, doi. 10.1093/infdis/jit805
- By:
- Publication type:
- Article
Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 11, p. 1703, doi. 10.1093/infdis/jit088
- By:
- Publication type:
- Article
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 12, p. 1936, doi. 10.1093/infdis/jir667
- By:
- Publication type:
- Article
Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Reply to Seligman.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 1, p. 174, doi. 10.1093/infdis/jir235
- By:
- Publication type:
- Article
HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 12, p. 1819, doi. 10.1086/657342
- By:
- Publication type:
- Article
Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection.
- Published in:
- Journal of Infectious Diseases, 2008, p. S294, doi. 10.1086/533419
- By:
- Publication type:
- Article
Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 12, p. 1779, doi. 10.1086/523648
- By:
- Publication type:
- Article
Elevated Cerebrospinal Fluid Neurofilament Light Protein Concentrations Predict the Development of AIDS Dementia Complex.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 12, p. 1774, doi. 10.1086/518043
- By:
- Publication type:
- Article
Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic Virological Suppression and Failure.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1686, doi. 10.1086/508750
- By:
- Publication type:
- Article
Prevalence of CXCR4 Tropism among Antiretroviral-Treated HIV-1--Infected Patients with Detectable Viremia.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 7, p. 926, doi. 10.1086/507312
- By:
- Publication type:
- Article
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis.
- Published in:
- Journal of Neurochemistry, 2021, v. 159, n. 1, p. 61, doi. 10.1111/jnc.15459
- By:
- Publication type:
- Article
Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment.
- Published in:
- BMC Infectious Diseases, 2005, v. 5, n. 1, p. 98, doi. 10.1186/1471-2334-5-98
- By:
- Publication type:
- Article
CSF neurofilament protein (NFL) – a marker of active HIV-related neurodegeneration.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 8, p. 1026, doi. 10.1007/s00415-006-0481-8
- By:
- Publication type:
- Article
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0250987
- By:
- Publication type:
- Article
3.7 How HIV leads to neurological disease.
- Published in:
- Medical Journal of Australia, 1996, v. 164, n. 4, p. 233, doi. 10.5694/j.1326-5377.1996.tb94148.x
- By:
- Publication type:
- Article
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236162
- By:
- Publication type:
- Article
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0226276
- By:
- Publication type:
- Article
CSF quinolinic acid levels are determined by local HIV infection: cross‐sectional analysis and modelling of dynamics following antiretroviral therapy.
- Published in:
- Brain: A Journal of Neurology, 2004, v. 127, n. 5, p. 1047, doi. 10.1093/brain/awh130
- By:
- Publication type:
- Article
Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 8, p. 1345, doi. 10.1093/cid/ciy1066
- By:
- Publication type:
- Article
Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1697, doi. 10.1093/cid/ciy362
- By:
- Publication type:
- Article
AIDS Dementia Complex and HIV-1 Infection: A View From the Clinic.
- Published in:
- Brain Pathology, 1991, v. 1, n. 3, p. 155, doi. 10.1111/j.1750-3639.1991.tb00655.x
- By:
- Publication type:
- Article
The urokinase receptor is overexpressed in the AIDs dementia complex and other neurological manifestations.
- Published in:
- Annals of Neurology, 2004, v. 55, n. 5, p. 687
- By:
- Publication type:
- Article
Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 3, p. 1, doi. 10.1371/journal.ppat.1004720
- By:
- Publication type:
- Article
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 5, p. 1, doi. 10.1371/journal.ppat.1003347
- By:
- Publication type:
- Article
HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 10, p. 1, doi. 10.1371/journal.ppat.1002286
- By:
- Publication type:
- Article
Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1-Associated Dementia.
- Published in:
- PLoS Pathogens, 2009, v. 5, n. 4, p. 1, doi. 10.1371/journal.ppat.1000395
- By:
- Publication type:
- Article
Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection.
- Published in:
- HIV Medicine, 2023, v. 24, n. 4, p. 442, doi. 10.1111/hiv.13411
- By:
- Publication type:
- Article